Author

Brianna J. Gysbers

Observed name: Brianna Gysbers

Institution: Mayo Clinic

Observed institution: Mayo Clinic

OpenAlex ID: A5077286275

The Lymphoma Epidemiology of Outcomes cohort study: Design, baseline characteristics, and early outcomes

2024 · James R. Cerhan, Matthew J. Maurer, et al. · American Journal of Hematology · 27

Cumulative Incidence, Predictors, and Outcomes of Transformation to Diffuse Large B-Cell Lymphoma in a Prospective Cohort of Patients with Marginal Zone Lymphoma

2023 · Côme Bommier, Brian K. Link, et al. · Blood · 3

Comparison of Methotrexate Maintenance Versus Autologous Stem Cell Transplant Consolidation after High-Dose Methotrexate-Based Induction Therapy in Primary Central Nervous System Lymphoma

2023 · Steven R Hwang, Patrick B Johnston, et al. · Blood · 2

Frontline Management Strategy and Quality of Life in Follicular Lymphoma: A Multi-Institutional Prospective Cohort Study

2023 · Mazie Tsang, Brie N. Noble, et al. · Blood · 1

Plasma methylated DNA markers of cutaneous melanoma: Association with PET/CT-positive disease.

2022 · Alexander Meves, William R. Taylor, et al. · Journal of Clinical Oncology · 1

Vulnerable Elders Survey (VES-13) and Longitudinal Analysis of Quality of Life in Indolent Non-Hodgkin Lymphoma: A Multi-Institutional Prospective Cohort Study

2024 · Mazie Tsang, Brie N Noble, et al. · Blood

Primary Central Nervous System Lymphoma and Contemporary Clinical Prognostication

2023 · Richard C. Godby, Steven R. Hwang, et al. · Blood

Lymphoma-Related Quality of Life (QOL) Is Not Impacted By Initial Treatment Choice in Patients with Marginal Zone Lymphoma (MZL): Results from the Prospective Lymphoma Epidemiology of Outcomes (LEO) Cohort

2023 · Côme Bommier, Mazie Tsang, et al. · Blood

Impact of Frontline Treatment Strategy on Quality of Life in the First Decade after a Diagnosis of Marginal Zone Lymphoma

2023 · Côme Bommier, Mazie Tsang, et al. · Blood

Lymphoid Malignancy Risk with Rare Inherited Variants in Known Cancer Predisposition Genes

2023 · Nicholas J. Boddicker, Raphael Mwangi, et al. · Blood

Abstract 5233: Germline CHEK2 variants and risk of lymphoma

2023 · Nicholas J. Boddicker, Raphael Mwangi, et al. · Cancer Research

Clinical Outcomes in Patients with Mantle Cell Lymphoma Who Received Autologous Stem Cell Transplant in the Second Line Setting

2022 · Jennifer Jane Gile, Allison M. Bock, et al. · Blood

Methylated DNA markers in urine aid in the selective identification of patients with prostate cancer as well as clinically significant pathology.

2022 · Paras Shah, William R. Taylor, et al. · Journal of Clinical Oncology

Sa287 DETECTION OF FAMILIAL AND GENETICALLY PREDISPOSED PANCREATIC CANCER BY ASSAY OF METHYLATED DNA MARKERS IN PANCREATIC TISSUE

2021 · Shounak Majumder, William R. Taylor, et al. · Gastroenterology

Sa304 METHYLATED DNA MARKERS IN TISSUE FROM SURGICALLY RESECTED INTRADUCTAL PAPILLARY MUCINOUS NEOPLASMS DETECT HIGH-GRADE DYSPLASIA WITH OR WITHOUT INVASIVE CANCER IN THE FIELD

2021 · Shounak Majumder, Rondell Graham, et al. · Gastroenterology

Molecular detection of pancreatic neuroendocrine tumors using methylated DNA markers: Discovery and tissue validation.

2020 · Shounak Majumder, Calise K. Berger, et al. · Journal of Clinical Oncology

Works count: 16

Citation count: 34

H-index: 2

I10-index: 1